Ascendiant Capital Maintains Buy on Aemetis, Lowers Price Target to $20
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsPrice Target
Ascendiant Capital analyst Edward Woo maintains Aemetis (NASDAQ:AMTX) with a Buy and lowers the price target from $22 to $20.
Ascendiant Capital analyst Edward Woo maintains Aemetis (NASDAQ:AMTX) with a Buy and lowers the price target from $22 to $20.